Abstract
Daratumumab (DARA) Plus Carfilzomib, Pomalidomide, Dexamethasone (KPd) in Lenalidomide Refractory Multiple Myeloma (MM): A Multi-Center MMRC Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have